Testosterone and women's well-being
IN the realm of women's wellness, the topic of sexual and reproductive health is often seen as taboo, being discussed in hushed tones if it's ever spoken about at all.
As things and times change, women are becoming more responsible with their health, and gone are the days when they have to sit in discomfort when it comes to intimacy.
IN the realm of women's wellness, the topic of sexual and reproductive health is often seen as taboo, being discussed in hushed tones if it's ever spoken about at all.
As things and times change, women are becoming more responsible with their health, and gone are the days when they have to sit in discomfort when it comes to intimacy.
Medical experts have now found a way to explore a transformative approach to restoring vitality, and that includes exploring the role of testosterone.
While this hormone is traditionally associated with men, testosterone also plays a vital role in women's well-being. Ovaries produce both oestrogen and testosterone, making it a naturally occurring hormone in a woman's body. With the help of the adrenal glands, the ovaries release small amounts of testosterone into the bloodstream helping to maintain muscle mass, bone density, energy levels and a healthy libido. However, as we age, the levels of testosterone in both men and women can gradually decline and when its levels drop, can lead to fatigue, decreased sexual desire and significant changes in mood.
In order to restore the natural order of things in the body, medical practitioners now suggest the use of testosterone cream, which has the potential to be a game-changer for women's intimate wellness. This alternative is becoming more popular than ever as a proven solution and is now readily available here in Jamaica. If used as directed by a physician, testosterone cream can replenish the levels of the hormone that may have declined over time.
Testosterone cream serves as a promising ally for women experiencing a decrease in sex drive during menopause. By delivering a controlled dose, women and their medical doctors can work to counterbalance the hormonal shifts that affect desire, arousal and satisfaction. While a low sex drive isn't always cause for concern in terms of physical health, it can have emotional and relational implications. The cream seeks to address this by potentially alleviating a range of symptoms, including reduced sexual thoughts, diminished pleasure and decreased energy contributing to a holistic improvement in a woman's intimate well-being.
Testosterone cream is typically applied directly to the skin and is best used on shoulders, upper arms or inner thighs so it can be quickly absorbed into the bloodstream.
While the use of testosterone cream offers promise, it's essential to approach it under the guidance of a health-care professional. Hormone levels need careful monitoring to ensure the treatment is tailored to each woman's unique needs and regular assessments and discussions with a medical provider can help ensure its effectiveness while minimising any potential risks. Using testosterone cream is a journey and results may vary, but with consistent use, women often report improved quality of life, both physically and emotionally.
Bodies change over time and it's time for women to feel more comfortable about exploring options that can enhance what we've already grown to know and love. If you've been feeling less vibrant or noticing changes in your energy and mood, testosterone cream could be a valuable tool in your wellness arsenal.
Dr Charles Rockhead is a consultant obstetrician gynaecologist at Amadeo Medical Group and Andrews Memorial Hospital. He can be contacted at 876-361-2355 or via email: drrockhead@gmail.com . Follow him on Instagram @amadeomedicalgroup and @oshuncosmeticservice
1 year 7 months ago
Scalp ringworm in children
IN recent months cases of scalp ringworm (Tinea capitis infection) among children have been increasing at an alarming rate in many countries.
Animal-to-human spread has been implicated as a route of infection, however the predominant spread has been directly from child to child at home or school, and through contaminated equipment and tools used at hair salons or barbershops. Most cases of the infection have been noticeable during and after summer months, in settings where hair tools and equipment are shared without keen attention being paid to hygiene and sanitation, especially during the month of August when hair-grooming activities increase ahead of students returning to school.
Description of scalp ringworm
Scalp ringworm is of two main types, namely: inflammatory and non-inflammatory. The infection is caused by a fungus that develops inside the hair follicle or on the scalp. The fungus causes the hair follicles to break and often results in itchy bald spots on the scalp or excessive scaling of the hair. Some individuals with scalp ringworm may also experience a low-grade fever, inflammation of the lymph nodes — in particular those located in the back of the head — and a pus-filled boggy mass that may occur at the affected area of the scalp. The fungus that causes the infection can also survive on surfaces for a long time. Contaminated hair linen, equipment, and tools such as combs, brushes, and shears are perfect mediums for the survival of the fungus.
Prevention of scalp ringworm infection
When considering using the services at a hair salon or barbershop ensure that:
(a) the establishment/facility is licensed by the municipality in which the business is located. Cosmetologists and barbers should also be certified by the Ministry of Health.
(b) the hair equipment, tools, and linen the cosmetologist or barber uses are washed and, where applicable, disinfected — whether through the application of heat sterilisation in an autoclave or through the use of chemicals such as a barbicide. Seventy per cent of isopropyl alcohol is acceptable as a disinfecting agent for hair tools and equipment.
When disinfection of hair tools and equipment is done by the use of chemicals or heat from an autoclave the tools and equipment must be allowed to remain for the required time in contact with the heat or the chemical. Spraying barbicide or alcohol onto hair equipment or tools and immediately wiping the said surface is unacceptable given the risk.
Avoid sharing personal items such as combs, hairbrushes, pillows, hats, and towels, particularly in communal settings such as schools and day-care establishments.
Due to the contagious nature of the fungus, parents, teachers, and childcare providers should take special precautions to ensure that children with scalp ringworm remain isolated from those who do not have the infection. Ideally, schools and day-care centres should have policies stipulating that a child receives medical attention once suspected of having the infection.
Hand washing is key in preventing this infection; cosmetologists, barbers, and caregivers should be careful to observe hand hygiene at required intervals. Children should be encouraged to wash their hands after play.
Bed linen should be changed and washed frequently, especially in communal settings where the likelihood of the spread of this infection is high.
If a pet is suspected of having ringworm pet owners should ensure the animal is seen by a veterinarian.
Areas where pets with the fungus have spent time should be properly disinfected. The spores of the fungus can be killed by applying ¼ cup of regular household bleach (5-9 per cent sodium hypochlorite) to one gallon of water onto a contaminated surface.
Treatment of scalp ringworm
Using over-the-counter medication such as shampoos may be effective in treating the infection in some instances, however individuals suspected of having the infection should seek medical attention so that the condition can be properly diagnosed and treated.
Scalp ringworm is not just a regular summer rash. The incidence of fungal infections such as scalp ringworm is a growing public health concern as, contrary to some beliefs, the infection is not an ordinary summer rash. Whilst the true burden of infections associated with fungal pathogens is difficult to assess it should not be ignored that since the year 2023 countries such as the United States of America and Mexico have reported emerging cases of drug-resistant ringworm infections. Greater regulatory controls and strategies geared towards ensuring improvement in sanitation and hygiene practices amongst the implicated trades and establishments are urgently required so that the incidence of scalp ringworm and other fungal infections such as those associated with cosmetic surgeries can be reduced or averted where possible.
Dr Karlene Atkinson is a public health specialist and lecturer at the School of Public Health, University of Technology, Jamaica.
1 year 7 months ago
Consumer wearable devices and heart health
ONCE the province of the professional athlete or the weekend warrior, the use of the consumer wearable devices (CWDs) has become more popular among the general population.
It estimated that by 2022 more than $1 billion of these devices would be in use worldwide. These devices allow the measurement of a variety of physiological data that was once confined to medical or research settings. Examples of these devices include the smart watch (eg, the Apple Watch, Samsung Galaxy watches, Garmin forerunner devices), heart rate monitors worn during exercise and a host of rings and bracelets with the ability to measure heart rate, assess sleep quality and duration, the amount and intensity of exercise and oxygen saturation.
With the increased frequency of use among the general population, our patients often turn to us for an explanation of the data obtained particularly when abnormal findings are seen. From the physician perspective, for a variety of reasons that we will discuss, it can be difficult to assess the clinical importance of these findings. For many types of data there are inadequate definitions of what is normal for a population or an individual. There are often real-world factors that can reduce device accuracy and each company can have propriety algorithms for generation of data that have not been tested against a gold standard.
Heart rate
There are several ways that heart rate can be obtained from a CWD. The two most common are the use of a chest strap to obtain a single lead ECG or the use of plethysmography in which light is used to penetrate the skin and subcutaneous blood vessels. This light is reflected to the device from the blood cells. The intensity and frequency of those reflections is used to generate a heart rate. Most watches, rings and bracelets use the second method to measure heart rate, although some watches can generate a single lead ECG that is user activated. When evaluated in research settings both methods give reasonable approximations of the heart rate when compared to a gold standard ECG; however, in "the real world" the accuracy tends to be less. A chest strap is generally more accurate than devices using plethysmography; however, a chest strap can be affected by motion causing artefact. It can also be affected by the type of exercise, for example, cycling vs running because of transient loss of contact with the skin or challenges with Bluetooth connection. A watch is generally more sensitive to motion resulting in lower accuracy. An important consideration for our population when using plethysmography devices is skin colour with higher doses of melanin as seen in black populations reducing the accuracy of some of these devices.
Most of our patients who follow their heart rates do so in the setting of exercise, where the heart rate is a reasonable proxy for the intensity of exercise, with higher heart rates being associated with more intense exercise. For runners or cyclists who want to exercise aerobically "so-called fat burning zone" using the heart rate to avoid going too hard is easily achievable. A common concern of our patients is the finding of a heart rate that they think is too fast or too slow. It is important to remember that the heart rate over 24 hours is not a number but is a range. On average the heart rate at rest ie, when sitting quietly is 60-100 beats per minute. This, however, can vary with several factors including age, sex, and level of fitness. A very well-trained endurance athlete can have a resting heart rate that is in the 30s as a normal finding. A normal heart rate will vary with activity and with emotional stress so that a rise in heart rate when walking, climbing stairs, being anxious or arguing with a friend or loved one is normal. It is also important to know that the heart rate can fall quite significantly with sleeping given the loss of activation of the "flight or fight" system with heart rates in the 30s being seen in some individuals.
When should we be concerned about the heart rate? Speaking anecdotally, most abnormalities that bring patients to see a cardiologist are found either to be normal findings or an inaccurate measurement by the CWD. If abnormalities in heart rate are associated with symptoms, then these are of more concern. Very slow heart rates and very fast heart rates (particularly at rest) should always be evaluated recognising that most times no significant abnormality will be found. Some CWDs can generate and record a single lead ECG, and these can be useful in trying to ascertain the clinical importance of heart rate abnormalities seen on these devices. Many of these patients will need medical grade rhythm assessment with electrocardiography or prolonged outpatient rhythm monitoring.
Atrial fibrillation
Atrial fibrillation is the most common sustained abnormal heart rhythm and is an important cause of stroke and heart disease. Many patients who experience atrial fibrillation will have symptoms of palpitations, but for some this arrhythmia is silent and the first recognition is when the patient presents with a stroke or heart failure. The ability of a smart watch or other CWD to detect atrial fibrillation thus allows for early identification and potentially early diagnosis and treatment. Atrial fibrillation, unlike normal sinus rhythm, is irregular and if an EKG is done there is no organised activity seen from the upper chambers of the heart. By looking at these features some smart watches can detect atrial fibrillation. Several devices have been approved for the detection of atrial fibrillation by either the US Food and Drug Administration or the European Medicines Agency. These include the Apple Watch, the Samsung Galaxy watch, several Fitbit devices and the Alivecor Kardiamobile device.
There is limited data on the real-world efficacy of these devices in detecting atrial fibrillation after approval particularly since smart watches tend to be used most in younger populations as opposed to the middle aged and elderly who are at greater risk of atrial fibrillation. A recent study was published in the Clinical Electrophysiology Journal of the American College of Cardiology comparing the efficacy of five consumer wearable devices in a group of patients who were undergoing evaluation and treatment for atrial fibrillation. Two hundred and eleven patients with an average age of 65 years were provided with smart watches, instructed on how to use them, and followed for approximately one year. The highest sensitivity was found with the Apple Watch 6 and the Samsung Galaxy 3, which detected around 85 per cent of atrial fibrillation episodes. The Fitbit sense detected 79 per cent of episodes. Among all watches rhythms were detected that the device was unable to classify approximately 20 per cent of the time; however, when a recording was available for review by a cardiologist a correct determination could be made in 95 per cent of the tracings. These findings suggest a potential use for consumer wearable devices in the detection of atrial fibrillation in patients at risk particularly with those devices that have undergone validation studies.
In future articles we will look further at other aspects of consumer wearable devices.
Dr Ernest Madu, MD, FACC and Dr Paul Edwards, MD, FACC are consultant cardiologists for the Heart Institute of the Caribbean (HIC) and HIC Heart Hospital. HIC is the regional centre of excellence for cardiovascular care in the English-speaking Caribbean and has pioneered a transformation in the way cardiovascular care is delivered in the region. HIC Heart Hospital is registered by the Ministry of Health and Wellness and is the only heart hospital in Jamaica. Send correspondence to info@caribbeanheart.com or call 876-906-2107.
1 year 7 months ago
Facts about prostate cancer
September
is Prostate Cancer Awareness Month, a time to raise awareness about prostate cancer and generate support for those affected by the disease.
Facts about prostate cancer
*Prostate cancer is one of the most common cancers among men.
September
is Prostate Cancer Awareness Month, a time to raise awareness about prostate cancer and generate support for those affected by the disease.
Facts about prostate cancer
*Prostate cancer is one of the most common cancers among men.
*This year, more than 160,000 men will be told they have prostate cancer.
*Some men are at higher risk for prostate cancer. Aside from age, risk factors for prostate cancer include family history and race.
*1 in 5 African American men will develop prostate cancer
*1 in 3 men with a family history will develop prostate cancer
*Nearly three million men in the US count themselves as prostate cancer survivors.
According to the American Urological Association:
*PSA screening in men under age 40 years is not recommended
*Routine screening in men between ages 40 to 54 years at average risk is not recommended
*For men ages 55 to 69, the decision to undergo PSA screening should be a shared decision made between the doctor and patient, after discussing the benefits and risks associated with screening and treatment
*Routine PSA screening is not recommended in men over age 70 or any man with less than a 10-15 year life expectancy
*Urologists are the front line of care and defence for most men and treat 80 per cent of all newly diagnosed cases of prostate cancer
1 year 7 months ago
One in three men worldwide are infected with genital human papillomavirus
A new study has been published in
The Lancet Global Health
showing that almost one in three men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and one in five are infected with one or more of what are known as high-risk, or oncogenic, HPV types.
A new study has been published in
The Lancet Global Health
showing that almost one in three men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and one in five are infected with one or more of what are known as high-risk, or oncogenic, HPV types.
These estimates show that men frequently harbour genital HPV infections, and emphasise the importance of incorporating men in efforts to control HPV infection and reduce the incidence of HPV-related disease in both men and women.
The systematic review and meta-analysis assessed the prevalence of genital HPV infection in the general male population based on studies published between 1995 and 2022. The global pooled prevalence was 31 per cent for any HPV and 21 per cent for high-risk HPV. HPV-16 was the most prevalent HPV genotype (5 per cent) followed by HPV-6 (4 per cent). HPV prevalence was high in young adults, reaching a maximum between the ages of 25 years and 29 years, and stabilised or slightly decreased thereafter.
Pooled prevalence estimates were similar for the UN Sustainable Development Goal geographical regions of Europe and Northern America, sub-Saharan Africa, Latin America and the Caribbean, and Australia and New Zealand (Oceania). The estimates for Eastern and South-Eastern Asia were half that of the other regions.
The majority of HPV infections in men and women are asymptomatic but they can lead to long-term sequelae and mortality. Each year, more than 340, 000 women die of cervical cancer. In men, HPV infection tends to manifest clinically as anogenital warts, which cause significant morbidity and increase HPV transmission rates. HPV infections are also associated with penile, anal and oropharyngeal cancers, which are commonly linked to HPV type 16. The International Agency for Research on Cancer estimated that there were about 69,400 cases of cancer in men caused by HPV in 2018.
"This global study on the prevalence of genital HPV infection among men confirms how widespread HPV infection is. HPV infection with high-risk HPV types can cause genital warts and oral, penile and anal cancer in men. We must continue to look for opportunities to prevent HPV infection and to reduce the incidence of HPV-related disease in both men and women," said Dr Meg Doherty, director of WHO's Global HIV, Hepatitis and Sexually Transmitted Infections Programmes.
1 year 7 months ago
Marijuana users have higher levels of heavy metals in blood: study - New York Post
- Marijuana users have higher levels of heavy metals in blood: study New York Post
- Heavy Metals in Marijuana: What Users Need to Know One Green Planet
- Cannabis users have much more lead and cadmium in their blood and urine, study finds USA TODAY
- International News: Heavy metal weed: study finds consumers may experience elevated levels of lead and cadmium in blood, urine Breaking Belize News
- Study detects significant levels of metals in the blood and urine among marijuana users News-Medical.Net
- View Full Coverage on Google News
1 year 7 months ago
Reappearance of serotype causes more dengue in the country
The presence of dengue serotype three is causing an increase in the number of disease cases in the country and a greater demand for medical care.
This serotype (DENV-3) has not circulated in the country for several years and, therefore, has found more susceptible people without contact with it.
The presence of dengue serotype three is causing an increase in the number of disease cases in the country and a greater demand for medical care.
This serotype (DENV-3) has not circulated in the country for several years and, therefore, has found more susceptible people without contact with it.
This was revealed yesterday by the Vice-Minister of Collective Health, Dr. Eladio Perez, who recalled that in general in the country, the one that has circulated the most each year is serotype 2, which has always been present in recent years.
He explained that although the severity of this dengue serogroup is not more significant, there is a lot of vulnerable population that does not have the immunity it has against serogroup 2, which has always been the most present in the Dominican territory.
Dr. Perez was interviewed while participating in the opening ceremony of the third Annual Meeting of Epistemic Communities 2023 held in the country with the theme Emerging Technologies and Community Empowerment, organized by Two Oceans In Health (2OIH).
Santo Domingo and Santiago
He reported that the presence of dengue serotype three was identified in Greater Santo Domingo and Santiago, among other locations in the country, but that, nevertheless, the endemic corridor has exceeded the number of cases expected to date. Still, it has not yet entered an unmanageable stage.
He informed that currently, the highest number of dengue cases is in Santo Domingo Norte, where interventions are being carried out by the Ministry of Public Health together with the Mayor’s Office and the National Health Service, with the removal of garbage, fumigation, and awareness and education.
He said that there is a greater affluence of patients coming to the health facilities’ consultation services but that the parameters of hospitalization remain within the expected.
In the region
“We have in the country a serogroup of dengue in the country the three, which had been found previously, but had already several years that was not present, in that sense there is a lot of vulnerable population,” said the deputy minister of collective health.
He pointed out that dengue is on the rise throughout the region, and data from the World Health Organization indicate that the Dominican Republic is the country with the best indicators.
In 2023, noted the Vice Minister of Public Health, the region of the Americas has experienced a significant increase in dengue cases. So far, more than 3 million new infections have been recorded, surpassing the figures for 2019, the year with the highest recorded incidence of this disease in the region with 3.1 million cases, including 28,203 severe cases and 1,823 deaths.
Four serotypes
The four dengue serotypes are DENV-1, DENV-2, DENV-3, and DENV-4, which circulate in the different countries of the Americas, and there may be cases where all of them circulate simultaneously.
According to experts, infection with one serotype followed by another condition with a different serotype increases a person’s risk of severe dengue fever and even death.
Dengue is transmitted to people by the bite of the Aedes aegyptis mosquito that breeds in clean water, especially that which accumulates in or around homes. The recommendations for its control are to eliminate containers that become breeding places, cover water used for domestic use, and go to the doctor at the first symptoms of the disease, which begins with sudden fever, pain behind the eyes and head, and general malaise.
Scientific meeting
The meeting of Epistemic Communities held yesterday in the country brought together renowned researchers who discussed different topics related to artificial intelligence and the role of technology and science in the face of future pandemics.
The renowned researcher Dr. Jeffrey V Lazarus, PhD, MIH, MA. Director of the Health Systems Research Group at ISGlobal, University of Barcelona, Spain, was in charge of the Inaugural Conference of the event, with the theme “Delphi Method as a catalyst of epistemic communities: international approach for the response to COVID-19 and future pandemics”.
The activity was organized by Two Oceans In Health (2OIH), which is a health research center dedicated to building knowledge that empowers communities in the Dominican Republic through Health Research, Data Management, and Academic Initiatives, led by researchers Eddy Perez Then and Marija Miric.
1 year 7 months ago
Health, Local
Health – Demerara Waves Online News- Guyana
Number of Georgetown street dwellers reduced- Human Services Minister
The number of street dwellers in commercial Georgetown has been reduced significantly and a number of them have been trained and employed, according to Minister of Human Services and Social Security Dr Vindhya Persaud. “Some people don’t like to abide by the rules. Some people like the street kind of conditions and some people refuse ...
The number of street dwellers in commercial Georgetown has been reduced significantly and a number of them have been trained and employed, according to Minister of Human Services and Social Security Dr Vindhya Persaud. “Some people don’t like to abide by the rules. Some people like the street kind of conditions and some people refuse ...
1 year 7 months ago
Health, News
PAHO/WHO | Pan American Health Organization
Zika: un virus silencioso que requiere mayor vigilancia y control
Zika: A silent virus requiring enhanced surveillance and control
Oscar Reyes
1 Sep 2023
Zika: A silent virus requiring enhanced surveillance and control
Oscar Reyes
1 Sep 2023
1 year 7 months ago
KFF Health News' 'What the Health?': 3 Health Policy Experts You Should Know
The Host
Julie Rovner
KFF Health News
Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to Z,” now in its third edition.
In this special episode, host Julie Rovner, KFF Health News’ chief Washington correspondent, interviews three noted health policy experts.
Amy Finkelstein is a health economist at the Massachusetts Institute of Technology and co-author of “We’ve Got You Covered: Rebooting American Health Care,” which posits a new approach to universal health insurance. Sylvia Morris is a physician and one of the co-authors of “The Game Plan: A Woman’s Guide to Becoming a Doctor and Living a Life in Medicine,” in which five former medical school classmates share things they wish they had known earlier about how to thrive in what is still a male-dominated profession. And Michael LeNoir is a pediatrician, allergist, former broadcaster, and health educator in the San Francisco Bay Area who founded the African American Wellness Project, aimed at helping historically underserved African American patients better participate in their own care.
Click to open the transcript
Transcript: 3 Health Policy Experts You Should Know
[Editor’s note: This transcript, generated using transcription software, has been edited for style and clarity.]
Julie Rovner: Hello and welcome back to “What the Health?” I’m Julie Rovner, chief Washington correspondent for KFF Health News. Normally I’m joined by some of the best and smartest health reporters in Washington. But today we have a very special episode. Rather than our usual news wrap, we have three separate interviews I did earlier this month with three very interesting guests: author and health economist Amy Finkelstein, author and physician Sylvia Morris, and physician and medical educator Michael LeNoir. So let’s get right to it.
I am pleased to welcome to the podcast Amy Finkelstein, professor of economics at the Massachusetts Institute of Technology, noted health policy wonk, and one of my favorite people in health care. She’s got a new book, just out, called “We’ve Got You Covered: Rebooting American Health Care.” Amy Finkelstein, welcome to “What the Health?”
Amy Finkelstein: Thanks so much for having me on, Julie.
Rovner: So it’s been a minute since large-scale health system reform was on the national agenda — I think, even in the research community — which is in some ways odd because I don’t think there’s ever been as much unanimity that the health system is completely dysfunctional as there is right now. But I’m starting to see inklings of ideas bubbling up. I interviewed Kate Baicker, your former partner in research, a couple of months ago, and I don’t know if you saw it, but there’s a new Republican health reform plan just out from the Hoover Institution. Why is now the time to start talking about this again?
Finkelstein: I mean, I think the right question is why haven’t we been talking about it all along? I think it’s, unfortunately, always timely to talk about how to fix the incredibly rooted rot in our health care quote-unquote “system.”
Rovner: Why has it been so hard to reach any consensus about how health insurance should work? We don’t … I mean, we’re at a point even in the United States where we don’t all agree that everyone should have health insurance.
Finkelstein: So it’s a really good question. I think my co-author, Liran Einav, who’s my long-term collaborator, and I came to realize in writing this book is that we weren’t getting the right answers and consensus on them because we weren’t asking the right questions, both as researchers and in the public policy discourse. There’s a lot of discussion of “What do you think of single-payer?” or “Should we have a public option?” or “What about health savings accounts?” But what we came to realize, and it’s kind of idiotically obvious once we say it, but it still unfortunately bears saying: You can’t talk about the solution until you agree on what is the goal. What are we trying to do in health policy and health policy reform? And there are, of course, many admirable reasons to want health policy reform, or government intervention, more generally, in health policy. You can think, and this is what we’ve worked on for many years, that, you know, Adam Smith’s “invisible hand” doesn’t work that well in medical marketplace. You can be interested in making sure that we try to improve population health. You can think that health care is a human right. There are many possible reasons. What we came to realize in working on this book, and what then provided startling clarity and, hopefully, ultimately consensus on the solution, is that while all of these may be admirable goals, none of them are actually the problem that we have been trying but failing to solve with our health policy for the last 70-plus years. What becomes startlingly clear when you look at our history — and it’s the same in other countries as well, they’ve just succeeded more than we have — is that there is a very clear commitment, or a social contract, if you will, that we are committed that people should have access to essential medical care regardless of their ability to pay. Now, that may sound absurd in the only high-income country without universal health coverage, but as we discuss in our book, that represents our failure to fulfill that commitment, not its absence. And as we describe in great detail, it’s very clear from our history of policy attempts that there is a strong commitment to do this. This is not a liberal or a conservative perspective. It’s, as we discuss, an innate and in some sense psychological or moral impulse. And once you recognize this, as people have across the political spectrum, fundamentally we’re not going to ever consciously deny access to essential medical care for people who lack resources, and that an enormous number of our existing policies have been a backhanded, scrambling, not coherently planned attempt to get there. And I’m not just talking about the requirement that people can’t be turned away from the emergency room. If you look at all of these public policies we have to provide health insurance if you’re poor, if you’re young, if you’re old, if you’re disabled, if you’re a veteran, if you have specific diseases — there’s a program for low-income women with breast and cervical cancer. There’s a program for people with tuberculosis, for people with AIDS, for people with kidney failure. All of these arose out of particular political circumstances and salient moments where we felt compelled to act. It becomes very clear that we’re committed to doing this, and then a solution then becomes startlingly simple, once we agree. And, hopefully, if you don’t already, our book will convince you that whether or not you support this mission, it’s very clear it is the mission we’ve adopted as a society. Then the solution becomes startlingly simple.
Rovner: And the solution is …?
Finkelstein: Universal, automatic, basic coverage that’s free for everyone with the option — for those who want to and can afford it — to buy supplemental coverage. So the key is that the coverage be automatic, right? We’ve tried mandating that people have coverage … requiring it doesn’t make it so. In fact, a really sobering fact is that something like 6 out of 10 of the people who currently lack insurance actually are eligible for either free or heavily discounted coverage. They just don’t have it. And that’s because there’s a very, very complicated series of paths by which you can navigate coverage, depending, again, on your specific circumstances: age, income, disease, geography, disability, what have you. Once you have patches like this, you’ll always have gaps in the seam. So that’s why it has to be universal and automatic. We also argue that it has to be free, something that may get us kicked out of the economists’ club because, as economists for generations, we’ve preached that patients need some skin in the game, some copays and deductibles, so they don’t use more care than they actually really need. And in the context of universal coverage, we take that back. It was kind of a really sobering moment for us. We’ve written enormously on this issue in the past. We weren’t wrong about the facts. When people don’t have to pay for their medical care, they do use more of it. We stand by that research. And that of many other …
Rovner: This goes back to Rand in the 1970s, right?
Finkelstein: Exactly. And the Oregon Health Insurance Experiment, which I ran with Kate Baicker, whom you mentioned earlier. It’s just that the implications we drew from that we’re wrong — that if we actually are committed to providing a basic set of essential medical care for everyone, the problem is, even with very small copays, there will always be people who can’t afford the $5 prescription drug copay or the $20 doctor copay. And there’s actually terrific recent work by a group of economists — Tal Gross, Tim Layton, and Daniel Prinz — that show this quite convincingly. So what we’ve seen happen when we look at other high-income countries that have followed the advice of generations of economists going back, as you said, to Rand, and introduced or increased cost sharing in their universal basic coverage system to try to reduce expenses, it’s extraordinary. Time and time again, these countries introduced the copays with one hand and introduced the exceptions simultaneously with the other — exceptions for the old, the young, the poor, the sick, veterans, disabled. Sound familiar? It’s the U.S. health insurance in a microcosm applied to copays. And so what you see happen, for example, in the U.K., that was famously, you know, free at the point of service when it was started in 1948, but then, bowing to budgetary pressures and the advice of economists introduced, for example, a bunch of copays and prescription drugs. They then introduced all these exceptions. The end result is that currently 90% of prescriptions in the U.K. are actually exempted from these copays. So it’s not that copays don’t reduce health care spending. They do. That economic research is correct. It’s that they’re not going to do that when they don’t exist. All we do is add complexity with these patches. So that’s, I think, the part that we can get up and stand up and say and get a lot of cheers and applause. But I do want to be clear, it’s not all rainbows and unicorns. We do insist that this universal, automatic, free coverage be very basic. And that’s because our social contract is about providing essential medical care, not about the high-end experience that obviously everyone would like, if it were free. And so …
Rovner: And that’s exactly where you get into these fights about how — even, we’re seeing, you know, with birth control and pretty much any prescription drug — you have to offer one drug, but there are other drugs that might be more expensive, and insurance plans, trying to save money, don’t want to offer them. You can see already where the tension points are going to end up. Right?
Finkelstein: Exactly. And every other country has dealt with this, which is why we know it can be done. But they do one thing that is startlingly absent from U.S. health policy. Besides the universal coverage part, they also have a budget. And it’s kind of both incredibly banal and incredibly radical to say, “We should have a budget in our U.S. health care policy as well.” Everything else has a budget. When school districts make education policy, they do it given a budget and they decide how to make tough choices and allocate money across different types of programming. Or they decide to raise taxes, and go to the voters to raise taxes to fund more. We don’t have a budget for health care in the U.S. When people talk about the Medicare budget, they’re not actually talking about a budget in the sense that when I give my kids an allowance, that’s their budget, and they have to decide which toy to buy or which candy to purchase. When we talk about the Medicare budget, we just mean the amount we have spent or the amount that Medicare will spend. There’s no actual constraint, and that has to change. And only then can we have those tough conversations, as every other country does, about what’s going to be provided automatically and for free, and what’s obviously nice and desirable, but not actually part of essential medical care and our social contract to provide it.
Rovner: But, of course, the big response to this is going to be — and I’ve covered enough of these debates to know — you’re going to ruin innovation if we have a budget, if we limit what we can pay, the way every other country does, that we’re not going to have breakthrough drugs or breakthrough medical devices or breakthrough medical procedures, and we’re all going to be the worse for it.
Finkelstein: That, I think, is a very real concern, but it’s not a problem for us, because if that’s the concern, when the next administration adopts our policy, they can set a higher budget. Right? If we think that we want to induce innovation, and the way to do that is through higher prices for medical care, then we can decide to pay more for it — or we can decide, oh, my goodness, right, get it coming and going. On the other hand, we don’t want to raise taxes. We don’t want to spend even more of public money on health care. OK, well, then we’ll decide on less innovation. That’s in some sense separable from universal, automatic, basic free coverage. We can then decide what level we want to finance that at. And also, to be clear, we fully expect, in the context of our proposal, that about two-thirds of Americans would buy supplemental coverage that would get you access to things that aren’t covered by basic or greater choice of doctor or shorter wait times. And so that, again, might also — but that would be privately financed, not publicly financed — but that would also help with the innovation angle.
Rovner: And this is not a shocking thing. This is exactly how Switzerland works, right?
Finkelstein: Yeah, the somewhat sobering or, dare I say, humbling realization we came to is that, as I said, we very much thought about this — I guess, as academics — from first principles, you know, what is the objective that we’re trying to achieve it? And given that, how do we achieve it? But once we did that and we looked around the rest of the world — right? — it turns out that’s actually what every other high-income country has done, not just Switzerland, but all of them have some version. And they’re very different on the details, but some version of automatic, universal, basic coverage with the ability to then supplement if you want more. So, with many things when you do research on them and then you run into the man on the street and they say, “Isn’t this simple? Can’t we just do what every other country does?” When it comes to health care delivery and how to cut waste and overuse and deal with underuse in the health care system, the man on the street is, unfortunately, wrong. And we have a lot more work to do to figure out how we can get more bang for our health care buck. But it turns out they were right all along. And we, or I and my co-author and many other, I think, academic economists and policymakers, just didn’t realize it, that actually the coverage problem has a really, really simple solution. And that’s the key message of our book.
Rovner: So one of the things that’s stuck with me for 15 years now is a piece that Atul Gawande wrote in The New Yorker just before the debate on the Affordable Care Act about how, yes, every other country has this, but, in fact, every other country had some kind of event that triggered the need to create a system. You know, in England, it was coming out of World War II. Every country had some turning point. Is there going to be some turning point for the U.S. or are we just going to have to sort of knuckle under and do this?
Finkelstein: So we deliberately steer clear of the politics in most of the book because our view is the question you started with, like, “Why can’t we agree?” So let’s at least … can we agree on the solution before we figure out how to achieve it? But, of course, in the epilogue, we do discuss this, you know, how could we get there? And I guess the main lesson that we take away from our read of history is that universal health insurance was neither destined to happen in every other country, nor destined not to happen in the U.S. We talk about several incredibly near-misses in the U.S. Probably the closest we got was in the early 1970s, when both the Republican Nixon administration and the Democratic Congress under Kennedy had competing proposals for universal coverage on the table. They were actually arguing over whether there should be copays when there are different accounts of whether the Democrats got overly optimistic with Watergate looming and thought they could get more, or some senator got drunk and had a car accident and Ways and Means got derailed. But we had a near-miss there. But also, and to your point about the U.K., more soberingly, if you look at the history of other countries, it wasn’t easy there. I mean, the British Medical Association threatened to go on strike before the implementation of the National Health Service in 1948. So, despite that, you know, now it’s … the National Health Service is as popular as the British monarchy — or actually more popular, perhaps …
Rovner: [laughs] Probably more!
Finkelstein: … and is beloved by much of the British population. But if you look at the narrative that this was destined to come out of the postwar consensus, the Labour leader, [Aneurin “Nye”] Bevan, who was pushing for it on the eve of its enactment, described the Tories as, quote, “lower than vermin for their opposition to it.” I mean, it was just … and similarly in Canada, when Saskatchewan was the first province to get universal medical insurance, there the doctors did go on strike for over three weeks. So this idea that every other country just had their destiny, their moment, when it clearly came together, and we were destined not to have it? Neither seems to be an accurate reading of history.
Rovner: Well, it’s a wonderful read. And I’m sure we’ll come back and talk again as we dive back into this debate …
Finkelstein: I’d love to.
Rovner: … which I’m sure we’re about to do. Amy Finkelstein, thank you so much for joining us.
Finkelstein: Thank you so much for having me.
Rovner: Hey, “What the Health?” listeners. You already know that few things in health care are ever simple. So, if you like our show, I recommend you also listen to “Tradeoffs,” a podcast that goes even deeper into our costly, complicated, and often counterintuitive health care system. Hosted by longtime health care journalist and friend Dan Gorenstein, “Tradeoffs” digs into the evidence and research data behind health care policies and tells the stories of real people impacted by decisions made in C-suites, doctors’ offices, and even Congress. Subscribe wherever you listen to your podcasts.
Next, we have Sylvia Morris, one of a group of friends who are women physicians who want to make it easier for the next generation of women physicians.
I am pleased to welcome to the podcast Dr. Sylvia Morris. She’s an internist from Atlanta and one of five authors of a new book called “The Game Plan: A Woman’s Guide to Becoming a Doctor and Living a Life in Medicine.” Dr. Morris, welcome to “What the Health?”
Sylvia Morris: Thank you so much for having me.
Rovner: So why does there even need to be a book about being a woman in medicine? Aren’t medical schools more than half women students these days?
Morris: They are. But when you look at some of the specialties, and once you get out into practice, women leaders are still not as plentiful. They are not 50%. So, we just wanted to write from our perspective some tips and tools of the trade.
Rovner: So before we talk about the book, tell us about how you and your co-authors got together. It is rare to find a book that has five listed authors.
Morris: Exactly. So we actually went to med school together. We were classmates at Georgetown, and we met, I will say, in the early ’90s, shall we say? 1992, 1993. And after we finished med school, as well as training, we started doing girls’ trips. Our first one was, like, to Las Vegas and then subsequently have just really evolved. And probably 10 years ago, we were sitting around in Newport Beach and we thought, you know what? We should figure out something to do to really, to give back, but also to share information that we didn’t have. I am a first-generation physician. Several of my co-authors are as well. And it would have been nice for someone to say, “Hey, Doc, maybe you should think about this.” So that’s why we wrote the book.
Rovner: I noticed that, yeah, I mean, you start very much at the beginning — like, way before med school and go all the way through a career. I take it that was very intentional.
Morris: Yes, because I don’t think most people wake up and decide they’re going to be a doctor and then apply to medical school. And although we all have different journeys, some of us decided to become physicians later. Later, meaning in college. I was a kid that always wanted to be a doctor. So at 5, I would say “I want to be a doctor,” and here I am a physician. So we really wanted to highlight the different pathways to becoming a physician and just so that people can just … we’re going to peel the curtain back on what’s happening.
Rovner: I love how sort of list-forward this book is. Tell us the idea of actually making a game plan.
Morris: Well, we’re big “list people.” I think in med school, you kind of learn, well, what’s your to-do list for today? You need to check that CBC. Yeah, you know, you have to follow up on physical therapy, all of those things. So lists become a really inherent part of how we do business. And I think people understand the list, whether it’s a grocery shopping list. So we wanted to be prescriptive, not specific, meaning you must do X, but here are some of the things that you need to think about. And a list is very succinct, and everyone can get it.
Rovner: Which leads right into my next question. I love how this is such a nitty-gritty guide about all of the balancing that everybody in such a demanding profession of medicine, but particularly women, need to think about and do. What do you most wish that you had known when you were starting out that you’d like to spare your readers?
Morris: If I could go back to my 17-year-old self who was just dropped off at Berkeley, I really would say, “Enjoy the ride.” And that sounds so trite, because we get very caught up in “it has to be this way.” And quite honestly, things have not turned out how I thought they were going to turn out. Certainly, in many ways, much grander and beyond my wildest imagination. But you do have to be intentional about what you want. So I’ve been very clear about wanting to be a physician, and I’ve worked along that path. It is never a straight line. So just embrace the fact that there are going to be some ups and some downs, but keep in focus on the goal and persevere. I’d like to borrow the word from Associate Justice [Ketanji Brown] Jackson, how she talked about persevere.
Rovner: I noticed that there are a number of places where there are key decisions that need to be made. And I think, you know, you talk about being intentional. I think people don’t always think about them as they’re doing them, as in deciding where to go to medical school, where to do a residency, what specialty to choose, what type of practice to participate in. The five of you are all in different specialties in different sort of practice modalities, right?
Morris: Yes, we are. And I think that that really adds to the richness of the book. And again, there’s no one way to get to your goal. But we have the benefit of being able to sort of bounce ideas off of each other. So if we are looking for a new job or kind of a career pivot, then we have someone to reach out to to say, “Hey. You did this. What are your thoughts? What should I look out for?”
Rovner: How important is it to have a support system? I mean, obviously, you talk about family and kids, but, I mean, to have a support system of friends and colleagues and people you can actually share stresses and successes with, that others will understand.
Morris: It is so important to know that you are not alone. There’s nothing new under the sun. So if you are going through something where we suffer in silence and isolation, that’s when bad things happen. So having a trusted group of friends, and whether it’s one person or three people — I’m lucky to have at least four people in my life that I can be candid and vulnerable with. It makes all the difference in the world. My mom died when I was in medical school, and having the support of my colleagues, my friends, to say, “Hey, yeah, you can keep going. You can do this.” That’s important. And there are some very low periods in residency, just because you’re tired all of the time. So having a group, whether it’s one or three or four, then please, have friends.
Rovner: I’m curious that while you are all African American women, you don’t really have a separate section on navigating medicine as members of an underrepresented group. Is that for another book entirely? Was there a specific reason that you didn’t do that?
Morris: I think certainly when people see us on the cover, then you’d realize, “Oh, they are women of African descent.” And I also think that because … women are still underrepresented in medicine, in particular in leadership, that we wanted to make sure we reached the broadest audience. And quite truthfully, our message works for not only women, but also works for men, it works for people of color. We just really wanted to say, “Hey, these are the things that we can think about when you are applying to medical school and as you embark on your career.” But I like the idea of a second book.
Rovner: Actually, that’s my … my next question is, what do you hope that men get out of this? Because, you know, flipping through, it’s a really good guide, not just to being a woman in medicine, but to being anyone in medicine or really anyone in a very time-demanding profession.
Morris: Yes, the word “ally” is kind of overused now, but I think that it gives the men in our lives, whether they be our partners and husbands, our fathers — I have a favorite uncle, Uncle William — to have an inkling of what’s happening and how to best support us. So I think that there’s just some valuable pearls.
Rovner: Well, thank you very much. It is a really eye-opening guide. Dr. Sylvia Morris, thank you for joining us.
Morris: Thank you.
Rovner: Finally for this special episode, here’s my chat with Michael LeNoir, a physician who spent much of his career trying to improve the health of African American patients.
We are pleased to welcome to the podcast Dr. Michael LeNoir, an allergist and pediatrician who spent the last 4½ decades serving patients in the East Bay of San Francisco and working to improve health equity nationwide. He’s a former president of the National Medical Association, which represents African American physicians and patients, and a founder of the African American Wellness Project, a nonprofit that grew out of the realization of just how large and persistent health disparities are for people of color. Dr. LeNoir, welcome to “What the Health?”
Michael LeNoir: Well, thank you so much.
Rovner: Health disparities and health equity have become, if you will, trendy research topics in the past couple of years in the health policy community because we know that people of color have worse health outcomes in general than white people, regardless of income. But this is hardly a new problem. When did it become obvious to you that, despite other civil rights advances, the health system is still not serving the Black community equally?
LeNoir: Well, I think it goes back to, actually, 2002, when as a doctor in a community that had people of color, physicians of color, I recognized that there was a difference in how African Americans were treated both professionally and personally. And it was such a stark difference. So I gathered together most of the Black health leaders in the Bay Area, some running hospitals, some running programs, two were directors of health, some Congress people, and some local politicians. And there were about 30 people in the room. And I … go around the room and asked, give me one instance where the health system that you engaged in treated you disrespectfully or you didn’t get information, or you felt abandoned without advocates. And we weren’t four people in when some people started crying about experiences that they’d all had. Now, I knew they had these experiences because of that as a doctor. You know, I’m in the doctor’s lounge as a consultant in allergy and immunology. I see the differences in how Black people were treated as opposed to whites. And I see the respect that was given to white physicians that was not given to Black physicians. So at that point, I decided, you know, there’s something upside down in this health system. The concept is that health is supposed to take care of you from the top down. Either your insurance company is supposed to take care of you, or the feds, or somebody. But my feeling was, you know, for African Americans the health system was not going to change unless we changed it from the bottom up. And so that’s when we started the African American Wellness Project to educate African Americans how to deal with some of the aspects of early detection, disease prevention, exercise, and things like that. But more importantly, what to happen when you have a problem, when you engage with the system. What tools do you need? What resources do you need? How do you get the best possible outcomes?
Rovner: So just this month, the Centers for Disease Control and Prevention released a survey that found that 1 in 5 women reported being mistreated by medical professionals during pregnancy or delivery. For Black women, it was closer to 1 in 3. This is clearly some sort of systemic problem even in addition to racism, isn’t it? The health system is not functioning well.
LeNoir: We did a piece on this yesterday because it’s pretty clear that this has been a problem as long as I’ve been a physician. Where it’s really a problem is the increasing incidence of maternal mortality among Black women. And so now we know that there’s something going on that’s not being taken care of. There’s one classic video that we show when we talk about this subject. It was a Black physician in Illinois who was in a small Illinois town, was in the intensive care unit, and could not get the care that she needed when she had covid respiratory issues. And so what happened was she was broadcasting from the ICU about what was being given to her, what was being talked to her about, what was not being done. And her care … when her symptoms were ignored, how they delayed in doing stuff. And she died four days after she did this video. But, you know, we’re not surprised. I mean, I see these studies of Black people don’t like the health care system. You know, Kaiser Foundation [KFF] must have spent, I don’t know how many dollars, looking at a study we did five years ago. On every study I’ve seen, Black people are not happy with the health care system. They had 12,000 people. We had 400. But the conclusions are the same. And it’s not so much because of the availability or the capacity of the health care system to close the gap on the health of Blacks and others in this society. It has a lot to do with unconscious bias and the fact that the system doesn’t recognize itself. And no matter how much you call attention to it, it continues year after year, decade after decade.
Rovner: Is there anything we can do about unconscious bias? I mean, now we all know it’s there, but that doesn’t seem to get around to fixing it.
LeNoir: There’s several things that have been talked about: change in medical schools and showing them more positive images so that when they come out of medical school, then the only patients that we see are poor, Black, uneducated, you know, down and out, because those are the ones that go to the VA hospital or the public hospitals. So that’s one thing. And the other thing is a Black person should call it out when they see it. That’s the big thing. And I think we’re much too docile in the health care system. Here’s what I always would feel is that if we get as mad about health care that is disrespectful and unequal as we do when someone cuts in front of us in the Safeway line, we wouldn’t have that problem.
Rovner: Seriously, I mean, so you think people really just need to speak up more?
LeNoir: Absolutely. And in the piece that we did yesterday, the piece was entitled “Health Care System Not Equal,” don’t put up with it.
Rovner: What can Black doctors do and how do we get more of them? I know that’s a big piece of this is that people don’t feel represented within the health care provider community.
LeNoir: Well, unfortunately, we know and probably you kno, and probably most patients know, that a good doctor may not be the smartest person in a medical school. They may have a variety of different prejudices and a variety of different talents or a variety of different capacity to engage patients in a positive way. But our medical system and our system that screens students for medical school really kinda looks more at analytics. I mean, what kind of grades you make, what your SATs look like, what kind of symbolic social things did you do in order to get into medical school? And so, consequently, that shuts out a lot of students at a very early place in the system. A Black student often goes into the system determined to be a doctor, but he doesn’t have those resources, those networks, those connections. So he bombs out in junior college. I can remember I had a unique educational experience. I went to a college-educated … well, middle school in Cincinnati. It’s called Walnut Hills High School No. 3. [To get in] you took a test, and my dad was a YMCA executive. So we moved to Dallas, Texas, which was completely segregated. So I recognized immediately when I got there that the learning experience was different, but the education was not. Because I learned as a Black student in an environment that was college preparatory that … I didn’t have many allies in that many networks. And my parents, like so many Black parents, said, there’s no excuses. You can’t … don’t be coming on with the excuse of discrimination, when we were facing it every day. And more than that, on the positive side, we’re not being encouraged like the white students were. When I got to Dallas, you know, we didn’t have all the books, we didn’t have all the stuff, but the teachers knew I had talent, and they pushed me and pushed me, pushed me. So when I went off to a university by choice — could have gone to Stanford, all these other places — that I had the talent. Whereas back in my high school there were students as good as I was as students. And then they went off to the University of Texas, where I ultimately transferred, which didn’t seem to be a big deal for me because I thought Howard actually was harder. But they go to the University of Texas, they were from a segregated school, and then by themselves and they bomb out … and so consequently they don’t get to realize the bigger part of themselves. So getting back to this question that you asked five minutes ago. The reason is that the parameters to choose people for medical school need to start earlier, and they need to encourage Blacks, especially Black males of talent, so they can then go on and do some things that are necessary to get into medical school.
Rovner: Yeah, I’ve seen some programs that are trying to recruit kids as young as 11 or 12 to gauge interest in going into a medical career.
LeNoir: Yeah, well, I think that’s, you know, that’s so unnecessary. But it’s a game. I mean, who is it … the doctor … your old Dr. So-and-So didn’t go to Harvard. So the talents to be a good doctor, you know, I don’t know whether you feel this way. I don’t think you can teach judgment by the time somebody gets out of high school. You know, physicians, the first thing I think that you have to have is good judgment, and good judgment can be sometimes assessed on the MCAT and these other things that they use to prioritize things for that.
Rovner: I know the Association of American Medical Colleges is very concerned about the Supreme Court decision that came down earlier this year banning affirmative action. Are you also worried about what that might mean for medical school admissions?
LeNoir: Well, you have to realize that in California, we’ve been dealing with this since the Bakke decision, so we’ve not been able … and I served on medical school committees. I served on the University of California-San Diego, and one year here at UC-San Francisco, kinda chaired the clinical faculty, so had the chance to kind of get engaged in policy here. And what we found out was that you can’t change that. You have to change the system itself.
Rovner: Yeah, I mean, how worried are you, obviously in California, I guess, things have gone OK, but it’s going to be a big change at a lot of other medical schools about how they’re going to go about admitting their next classes and trying to at least further more culturally diverse classes of medical students.
LeNoir: Well, you know, California’s not done OK. I mean the percentage of California students — I believe diversity in California is probably 50% less than it was in the days when we had more liberal affirmative action guidelines. And so in those days, we were reporting 24, 25 Black students in these classes. That’s not happening anymore. So … I do worry. I mean, the reality is right in front of us. And I think that some schools … not necessarily the schools themselves, but the politicians that supervise these schools that have oversight over these schools are going to use this as a weapon. I know that already many of the attorney generals have sent letters to the university saying, look, I don’t care what you do, it’s not going to happen anymore. And the first persons to leave jobs now are diversity. Good jobs in diversity management … those jobs are disappearing almost as we speak.
Rovner: So if you could do just one thing that would help the system along to make things a little bit less unequal, what would it be?
LeNoir: I think it would be making certain that the system has the tools to detect two types of unconscious bias: this personal unconscious bias on the part of providers, but this institutional unconscious bias. And I think we have to attack that first. Institutions don’t look at African Americans the same way. And here’s … let me give you an example of what that falls out to. Let’s look at the statistics on vaccinations in ethnic groups. The impression is that Black people didn’t get vaccinated. But at the end of the day, if you looked at the numbers, we were vaccinated pretty much about the same level as the rest of America. But when we got ready to look at this, what we found out is hesitancy was based upon the fact that Black people did not trust the system. And institutions are expected to come out, here you are, you know, you’re part of an institution. You see a different doctor every week. And they come out to tell you you’re supposed to do your shots and stuff like that. Then Black people don’t believe that. They don’t go, they don’t go with that. And so consequently, at the end of the day, once the information came out and people got a chance to look at it, we started getting vaccinations at the same rate. But the people who are asking us to trust them had never attempted institutionally to obtain our trust. And so I think under those circumstances, that’s one of the reasons, that’s one of the things we most have to attack is institutional unconscious bias, institutional racism that’s covered over by the fact that we’re taking care of the poor. You know, we do all these things here and there, but poor people have opinions, too. And if we expect to change the system where everybody is treated equally, we have to look at what the institutional policies, or the institutional character or personality that results in the kinds of outcomes that we see in hospitals. And then we start looking at providers and other people. And they have to start engaging in this community now. There’ll be another pandemic, you know that. I know that. Probably this summer, this winter, things are going to … Look, what have doctors done? What have institutions done to gain the trust of the populations they serve? Probably nothing.
Rovner: Well, we’ve seen, you know, one of the things the pandemic has shown us is that now all Americans don’t trust institutions anymore. Is there maybe even a way to help everyone gain more trust? I mean, I guess it’s becoming much more obvious to at least the public health community that much of the public in general is distrustful of public health advice, of medical advice, of expertise in general.
LeNoir: Oh, yeah, there’s no question. This is not a unique problem among African Americans. I mean, it’s hard to trust a system where you have a problem and your doctor refers you somewhere and your next appointment is four months away. And here’s what the tragedy is: Nobody in Washington is talking about changing the system. I can remember the big furor over what were we going to do? Are we going to do single-payer? Are we going to do this? At least there was a dialog. Have you heard a dialog in Washington about changing this awful health care system that denies people access, overcharges them, and then is not blamed for the outcomes? I haven’t seen any of that. I haven’t seen anybody talk about health care at the national level. We used to do pieces, I remember years ago when I worked for CBS Radio, I tried to get a curriculum for hypertension, diabetes. Now you barely see anything on health except violence, and you don’t see too many pieces that people could use for health education. So I think the system is really broken and nobody’s … I don’t see any, even in the discussions last night [during the first Republican presidential primary debate], health never came up. You know, Ukraine, but not the health care system, which is really cheating us all.
Rovner: Yeah, I know. I mean, we’re … an entire Republican debate, and there was not a single mention of the Affordable Care Act or anything else that Republicans might want to do to fix a health care system that I think even Republican voters know is broken.
LeNoir: Yeah, I think that [Donald] Trump has sucked all the oxygen out of the room. And they’re not talking policy very much at all. I mean, even the undertones of the policy discussions have Trump all over it. So I think we’re in a very bad place, but I hate to see that escalating discussion on how to change the health care system, not just for the good of the poor people and Black people, I don’t think white people are really particularly excited about the system, and that dialog is not taking place.
Rovner: Is there anything you can offer that’s at all optimistic about this?
LeNoir: Well, no. No, I really can’t. As a doctor, I can tell you. Here’s the expanding issue. It just seems now that the solution to all the health problems that we have are the social determinants of health. I mean, you know, income and poverty and food, you know, issues and employment, all of that, they all contribute definitely to health outcomes. And so until we change those, then obviously the system, they say, will not change. Every chronic disease that I’ve looked at over the last 10 or 15 years, and especially recently, what Black people don’t do as well, it’s not because they don’t get into the system at the right time. They may even have early disease detection. It’s because they are not treated the same way. So if you look at statistics, all Black women have more deaths from breast cancer, our Black children have more asthma. It’s not because they don’t enter the system. It’s how they’re treated when they get into the system. So then going back to what we can do, we have to arm the patient, Black or white, to understand what you need to do to get the most effective outcomes. How do you select your primary care doctor? It’s critically important to everything that happens to you. How you’re able to challenge the system with a second opinion when you want that. To have an advocate, if you go into the hospital, not your brother or sister, but somebody who knows something about health care. So what we’re trying to do with the African American Wellness Project is to do that. We talk about early detection. Here’s the other problem with this. Now, I’d rather have penicillin than get rid of poverty or to get everybody a job. And in the New England Journal probably maybe a week ago, there was an editorial about how we as physicians should be able to manage the other elements, the social determinant elements, as part of our visits. Now I’ve barely got enough time to see the patients that I have. Now I’m supposed to get somebody food, a job and all that … but I’m not saying that that doesn’t need to change. It does. But if every solution to the problem of health equity is the social determinants like I’m seeing, then I mean, we might not get penicillin, but we may get somebody a job. But I think that that that process is important. It is important. But if you look at studies that at the VA, especially with men with prostate cancer, or if you have prostate cancer and … everything’s done exactly the same: early detection, the PSAs, the biopsy, the identification — the prostate is done not by biopsy, but by MRI — and they treat it the same, Black people do better. And the same thing is true with breast cancer and other chronic diseases. All these studies. You can go to PubMed, and you look at all these studies and you see every study talks about that, that the reason that they’re not doing as well, is because of the social determinants of health. Now, I mean, I appreciate that, but I’m not going to wait for everybody to get a job before I try to get a stent put in my artery, or I try to get some concern for my position. So to go back to your question again that you asked me five minutes ago, is that we need to talk to people about the system they face, and they need to go into it with less naivete and more organization. And that’s what we try to do with the African American Wellness [Project]. We try to provide you with that information and the tools that you need when you need to go into the system. If you need to know what questions to ask … we’ll tell you how to do that. One of the things I found out is I engage social media as a way to talk to people, because I’ve always used traditional media and, boy, I recognize now that you have to do it a little differently. You can’t do it exactly the same way. And so I just think we have to prepare people and we have to tell them the things that they need to do to recognize and understand before they enter the system. Until we start to get more serious in this country, about that dialog on our health care system, I think the individual is the only way we can approach it.
Rovner: Dr. LeNoir, thank you. Thank you so much for all of what you’re doing and thank you for joining us today.
LeNoir: Thank you for having me.
Rovner: OK, that’s our show for this week. As always, if you enjoy the podcast, you can subscribe wherever you get your podcasts. We’d appreciate it if you left us a review; that helps other people find us, too. Special thanks, as always to our amazing engineer, Francis Ying. And also, as always, you can email us your comments or questions. We’re at whatthehealth@kff.org. Or you can tweet me or X me or whatever. I’m still @jrovner, also on Bluesky and Threads. I hope you enjoyed this special episode. We’ll be back with our regular podcast panel after Labor Day. Until then, be healthy.
Credits
Francis Ying
Audio producer
Stephanie Stapleton
Editor
To hear all our podcasts, click here.
And subscribe to KFF Health News’ ‘What the Health?’ on Spotify, Apple Podcasts, Pocket Casts, or wherever you listen to podcasts.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.
USE OUR CONTENT
This story can be republished for free (details).
1 year 7 months ago
Insurance, Multimedia, Race and Health, KFF Health News' 'What The Health?', Medical Education, Podcasts
PAHO/WHO | Pan American Health Organization
Director de la OPS pide dar mayor respuesta a las necesidades de salud de los afrodescendientes
PAHO Director calls for greater response to health needs of people of African descent
Cristina Mitchell
31 Aug 2023
PAHO Director calls for greater response to health needs of people of African descent
Cristina Mitchell
31 Aug 2023
1 year 7 months ago
Alarm due to the increase in childhood overweight and obesity in Latin America and the Caribbean
Santo Domingo.- UNICEF has raised concern over the rising prevalence of childhood overweight and obesity in Latin America and the Caribbean, which surpasses the global average. The organization has urged countries in the region to prioritize the prevention of this condition as a national public health goal.
Santo Domingo.- UNICEF has raised concern over the rising prevalence of childhood overweight and obesity in Latin America and the Caribbean, which surpasses the global average. The organization has urged countries in the region to prioritize the prevention of this condition as a national public health goal.
In children under 5 years old, overweight prevalence increased from 6.8% (3.9 million people) in 2000 to 8.6% (4.2 million) in 2022. For children and adolescents aged 5 to 19, the prevalence of overweight rose from 21.5% (35 million people) in 2000 to 30.6% (49 million) in 2016. This alarming trend is attributed to obesogenic food environments that promote consumption of unhealthy products high in sugar, fat, and salt, as well as limited physical activity.
Overweight and obesity in childhood and adolescence can lead to non-communicable diseases like diabetes, cardiovascular issues, hypertension, cancer, and a shorter life expectancy. UNICEF’s regional director for Latin America and the Caribbean, Garry Conille, emphasized the need to prioritize the health and well-being of children and adolescents.
UNICEF called for countries to declare the prevention of childhood overweight as a national public health priority, involving key stakeholders such as the public sector, academia, civil society, and the private sector.
The organization also stressed the importance of analyzing the causes of childhood overweight on a country-by-country basis and implementing evidence-based interventions that prioritize children’s rights. Increased public investment and resource allocation for prevention efforts, including surveillance and monitoring systems, are also recommended.
1 year 7 months ago
Health
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Pedal power pays off: Mountain biking benefits outweigh risk
New Curtin research into injuries sustained by trail users has found mountain biking is not the dangerous, injury-plagued sport reserved for thrill-seekers that it is often perceived to be and that the health benefits outweigh the risks.
Researchers analysed data from dozens of studies across the world, including Australia, encompassing 220,935 injured mountain bikers and 17,757 injured hikers. The study aimed to pinpoint the injury types and affected body areas in order to gain insights into the medical treatment of such cases.
Lead author PhD candidate Paul Braybrook, from Curtin’s School of Nursing, said mountain bikers were primarily injured on their upper limbs, mostly resulting in bruises, scratches and mild cuts while hikers were prone to injuring their legs and ankles, suffering mostly blisters and ankle sprains.
“Mountain biking and hiking are some of the fastest growing recreation activities in the world, so understanding the spectrum of injuries becomes paramount for effective medical care,” Mr Braybrook said.
“Despite a common perception of mountain biking as an ‘extreme’ sport, we found most reported injuries were of low severity. Although there were high proportions of ankle sprains in hikers and arm fractures in mountain bikers, with one study of the latter reporting more than half suffered head injuries, highlighting the importance of a good quality helmet.
“As the popularity of both pursuits has increased, so too has the standard of trails, bikes, footwear and protective gear, reducing the risk of serious injury.
“In the case of mountain biking there has also been a cultural shift from the more extreme or ‘radical’ style of riding synonymous with the sport when it first evolved decades ago in places like Colorado and California.”
Mr Braybrook said the risk of injury from mountain biking or hiking was outweighed by the considerable benefits.
“Mountain biking and hiking bring economic gains through tourism and the obvious health benefits of physical activity including improvements in cardiovascular health and reducing the risk of high blood pressure, obesity, high blood cholesterol, and type 2 diabetes,” Mr Braybrook said.
“With Spring weather upon us, people should take the opportunity to regularly head out to their nearest trail for a ride or hike – these are fun activities, great for fitness and with only the occasional scratch or bruise likely to result.”
Reference:
Paul John Braybrook ,Hideo Tohira,Tanya Birnie,Deon Brink,Judith Finn,Peter Buzzacott, Types and anatomical locations of injuries among mountain bikers and hikers: A systematic review,https://doi.org/10.1371/journal.pone.0285614.
1 year 7 months ago
Medicine,Medicine News,Top Medical News,Latest Medical News
Health & Wellness | Toronto Caribbean Newspaper
Once in a blue moon
BY AKUA GARCIA Greetings Star Family! I pray this finds you well and in good spirits. This summer has been one hell of a ride. Fires popping up everywhere, changes in the economic landscape with BRICS pushing ahead, contact with aliens, inflation still rising, boosting up the costs of everyday living and now we have […]
The post Once in a blue moon first appeared on Toronto Caribbean Newspaper.
1 year 7 months ago
Spirituality, #LatestPost
US Government thanked for disaster management support
Two field hospitals costing approximately US$1 million were donated by the United States Government in March 2022 for emergency purposes
View the full post US Government thanked for disaster management support on NOW Grenada.
Two field hospitals costing approximately US$1 million were donated by the United States Government in March 2022 for emergency purposes
View the full post US Government thanked for disaster management support on NOW Grenada.
1 year 7 months ago
Carriacou & Petite Martinique, Community, Health, PRESS RELEASE, field hospital, frances herrara, Javan Williams, jorge oritz, ministry of carriacou and petite martinique affairs, nadma, terrance walters, united states embassy, western shelters systems
Dominican Republic continues without detecting cases of the EG.5 variant of COVID-19
Santo Domingo.- As of now, the Dominican Republic has not detected any cases of the new EG.5 variant of COVID-19. Dr. Manuel Gil, while presenting the weekly epidemiological bulletin on the country’s COVID-19 situation, mentioned that the surveillance system is actively monitoring for the variant and is prepared to respond promptly if any cases are identified.
Santo Domingo.- As of now, the Dominican Republic has not detected any cases of the new EG.5 variant of COVID-19. Dr. Manuel Gil, while presenting the weekly epidemiological bulletin on the country’s COVID-19 situation, mentioned that the surveillance system is actively monitoring for the variant and is prepared to respond promptly if any cases are identified.
Dr. Gil clarified that the EG.5 variant doesn’t raise significant concerns as it exhibits low pathogenicity. This is a common evolutionary pattern for viruses, where they may evolve to a point where they either show no symptoms or the symptoms are not severe.
This week, Ecuador’s Ministry of Public Health confirmed the discovery of three cases of the EG.5 variant within their country. This variant has caused an increase in cases in several other countries including China, Canada, Colombia, Costa Rica, and the United States.
In the past week, the Dominican Republic reported 125 new cases of COVID-19 out of 3,729 samples processed. The weekly positivity rate is 8.87%. The provinces with the highest number of active cases include Santiago, Espaillat, Duarte, San José de Ocoa, the National District, Santo Domingo, San Pedro de Macorís, La Altagracia, and San Juan.
1 year 7 months ago
Health
Health Archives - Barbados Today
Scotiabank partners with Variety to offer speech therapy to children in need
Speech therapy plays an important role towards the holistic development of children. It improves overall communication, enhances social skills and enables them to cope better with society and function in day-to-day life. Early intervention and treatment can significantly enhance the lives of children and allow them to better integrate into their environment. To help children get the support they need, Scotiabank has contributed to a Speech Therapy Project with Variety – The Children’s Charity at the Albert Cecil Graham Development Centre (ACGDC).
Under this project, speech-language therapy intervention will be provided at the ACGDC to enrich the lives of children, increase the effectiveness of the service and assist in reducing the extended waiting list.
Marita Greenidge, Executive Director, Variety commented: “We are considerably grateful for this donation from Scotiabank. This support will aid in reducing the extensive waiting list for speech-language therapy at the ACGDC. Treating speech and language defects can promote increased self-confidence, better academic outcomes and wider social acceptance for children receiving therapy. We are thankful that Scotiabank is so passionate about driving inclusivity and removing barriers to advancement. Variety believes every child deserves a limitless future and we are overjoyed to work with caring partners like Scotia who want to help build a brighter future for this island’s most vulnerable.”
Suzette Armoogam-Shah, Managing Director, Scotiabank Barbados signalled the bank’s ongoing support for developing young people.
“How we support children today will enable their success in the future. Furthermore, it is important for all children to be afforded the same opportunities so that they can go on to lead successful lives. We are truly pleased to work with Variety on this project. It helps ensure that children in need of speech therapy achieve their full potential, feel a sense of belonging in our communities, and may even go a step further in acting as a source of inspiration to others.” (PR)
The post Scotiabank partners with Variety to offer speech therapy to children in need appeared first on Barbados Today.
1 year 7 months ago
A Slider, Business, Education, Health
PAHO/WHO | Pan American Health Organization
Director Statement on the Evaluation Report of PAHO’s Technical Cooperation in the Prevention and Control of NCDs in the Americas
Director Statement on the Evaluation Report of PAHO’s Technical Cooperation in the Prevention and Control of NCDs in the Americas
Cristina Mitchell
30 Aug 2023
Director Statement on the Evaluation Report of PAHO’s Technical Cooperation in the Prevention and Control of NCDs in the Americas
Cristina Mitchell
30 Aug 2023
1 year 7 months ago
Model Jennifer Barlow has her leg amputated due to flesh-eating bacteria - Marca English
- Model Jennifer Barlow has her leg amputated due to flesh-eating bacteria Marca English
- US woman, 33, loses leg after contracting 'rare, flesh-eating bacteria'. See post Moneycontrol
- 'I decided to fight:' VB woman loses leg while battling sepsis for 10 weeks after giving birth News 3 WTKR Norfolk
- US Woman, 33, Loses Leg After Getting Flesh-Eating Bacteria In Bahamas NDTV
- View Full Coverage on Google News
1 year 7 months ago
Health – Demerara Waves Online News- Guyana
British NGO-funded UG-affiliated biodiversity research centre isn’t about exporting science- co-founder
The University of Guyana (UG) on Tuesday formally announced the establishment of a not-for-profit biodiversity research centre in the Essequibo River near the Mazaruni and Cuyuni rivers with an assurance by the British non-governmental organisation that the aim is not to export scientific information from the area. Co-founder of the Sophia Point Rainforest Research Institute, ...
The University of Guyana (UG) on Tuesday formally announced the establishment of a not-for-profit biodiversity research centre in the Essequibo River near the Mazaruni and Cuyuni rivers with an assurance by the British non-governmental organisation that the aim is not to export scientific information from the area. Co-founder of the Sophia Point Rainforest Research Institute, ...
1 year 7 months ago
Business, Education, Health, News, Politics